1Mintun MA,Welch MJ,Siegel BA,et al.Breast cancer:PET imaging of estrogen receptors[J].Radiology,1988,169(1):45-48.
2Peterson LM,Mankoff DA,Lawton T,et al.Quantitative imaging of estrogen receptor expression in breast cancer with PET and 18F-fluoroestradiol[J].J Nucl Med,2008,49(3):367-374.
3Gemignani ML,Patil S,Seshan VE,et al.Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancer[J].J Nucl Med,2013,54(10):1697-1702.
4Simmons C,Miller N,Geddie W,et al.Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases[J]?Ann Oncol,2009,20(9):1499-1504.
5Amir E,Miller N,Geddie W,et al.Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer[J].J Clin Oncol,2012,30(6):587-592.
6Yang Z,Sun Y,Zhang Y,et al.Can fluorine-18Fluoroestradiol positron emission tomography computed tomography demonstrate the heterogeneity of breast cancer in vivo[J].Clin Breast Cancer,2013,13(5):359-363.
7Fowler AM,Chan SR,Sharp TL,et al.Small-animal PET of steroid hormone receptors predicts tumor response to endocrine therapy using apreclinical model of breast Cancer[J].J Nucl Med,2012,53(7):1119-1126.
8van Kruchten M,Glaudemans AW,de Vries EF,et al.PET imaging of estrogen receptors as a diagnostic tool for breast cancer patients presenting with a clinical dilemma[J].J Nucl Med,2012,53(2):182-190.
9Linden HM,Stekhova SA,Link JM,et al.Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast cancer[J].J Clin Oncol,2006,24(18):2793-2799.
10Mortimer JE,Dehdashti F,Siegel BA,et al.Metabolic flare:indicator of hormone responsiveness in advanced breast cancer[J].J Clin Oncol,2001,19(11):2797-2803.
